Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Primary Healthcare Systems Advancements in LMICs
Transforming Healthcare: South Africa’s NHI Law Signed
The Influence of AI on Risk Adjustment Models in Healthcare
Economic Impact of Diabetes and High-Deductible Health Plans
The Economic Burden of End-Stage Renal Disease in Sudan
The Crucial Role of Pharmacogenetic testing in Thiopurine Therapy
High Court on South African National Health Insurance Bill
Reforming Primary Healthcare with Pharmacy First Initiative
Value-Based Medication Benefits in Diabetes Management
AI in Healthcare Advancements
CMS Final Rule: Streamlining the Prior Authorisation Process
A Glimpse into the PBAC December 2023 Meeting Outcomes
« Previous
1
…
3
4
5
6
Next »